Advertisement
Screener

BIOTRICITY INC. (BTCY) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.6 / 5 stars · 40/76 Roast Me

BIOTRICITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

BIOTRICITY INC. (BTCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 9-month period ending 2025-12-31, per its 10-Q filed 2026-02-11.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-07-14

  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-06-30 was 0.00%.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-06-30 was 0.00%.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-06-30 was 0.00%.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-06-30 was 0.00%.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2025-12-310.00%
10-Q · filed 2026-02-11
2025-09-300.00%
10-Q · filed 2025-11-14
2025-06-300.00%
10-Q · filed 2025-08-14
2025-03-310.00%
10-K · filed 2026-07-14
2024-12-310.00%
10-Q · filed 2026-02-11
2024-09-300.00%
10-Q · filed 2025-11-14
2024-06-300.00%
10-Q · filed 2025-08-14
2024-03-310.00%
10-K/A · filed 2025-07-18
2023-12-310.00%
10-Q/A · filed 2025-02-20
2023-09-300.00%
10-Q · filed 2024-11-14
2023-06-300.00%
10-Q · filed 2024-08-19
2023-03-310.00%
10-K · filed 2024-06-27
2022-12-310.00%
10-Q · filed 2024-02-20
2022-09-300.00%
10-Q · filed 2023-11-14
2022-06-300.00%
10-Q · filed 2023-08-14
2022-03-310.00%
10-K · filed 2023-06-29
2021-06-300.00%
10-Q/A · filed 2021-08-17
2021-03-310.00%
10-Q · filed 2022-11-14
2020-03-310.00%
10-Q · filed 2022-11-14
2019-03-310.00%
10-Q/A · filed 2021-08-17
2018-03-310.00%
10-Q · filed 2020-11-13
2017-03-310.00%
10-Q · filed 2020-11-13
2016-03-310.00%
10-Q · filed 2020-11-13
2015-12-310.00%
8-K · filed 2016-04-13